Cytokinetics, Incorporated (NASDAQ: CYTK ) is a cardiology company with a late-stage pipeline that includes Aficamten. This is a therapy for obstructive hypertrophic cardiomyopathy (oHCM). Aficamten has a PDUFA date that was delayed to December 2025, with an FDA My name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio University, Athens, OH, USA, a graduate de ...